Stock listing
Lipigon Pharmaceuticals Ab
Selected listing: 9RP · SWB · EUR · DE
Lipigon Pharmaceuticals Ab (Stuttgart:9RP), Health Technology. Latest release Dec 22, 2025: PLX: Secarna’s Antisense Oligonucleotide Discovery Collaboration.
- Ticker
- Stuttgart:9RP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Stuttgart
- Currency
- EUR
About Lipigon Pharmaceuticals Ab
Lipigon Pharmaceuticals Ab (ticker: LPGO) is a public company based in Sweden, focused on developing innovative therapies for lipid-related diseases. The company is committed to advancing its research and development efforts to bring new treatments to market.
Latest news from Lipigon Pharmaceuticals Ab
Research Lipigon Pharmaceuticals Ab
Lipigon Pharmaceuticals Ab company profile
View the public company page for Lipigon Pharmaceuticals Ab on 6ix.
Lipigon Pharmaceuticals Ab news
Read company news and market updates connected to Lipigon Pharmaceuticals Ab.
Lipigon Pharmaceuticals Ab investor events
Find investor webinars, events, and replay context for Lipigon Pharmaceuticals Ab.
Alternate listings
LPGO:OMXSTO
SE · SEK
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is 9RP:SWB.
A2QP0Q:LSX
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is 9RP:SWB.
9RP:FWB
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is 9RP:SWB.
9RP:GETTEX
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is 9RP:SWB.
A2QP0Q:LS
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is 9RP:SWB.
9RP:MUN
DE · EUR
Alternate listing for Lipigon Pharmaceuticals Ab; the primary context on this page is 9RP:SWB.